Security key
69366J200
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)
CUSIP: 69366J200
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 81,782,297
- Total 13F shares
- 79,911,059
- Share change
- +1,115,135
- Total reported value
- $3,903,121,530
- Put/Call ratio
- 59%
- Price per share
- $48.84
- Number of holders
- 281
- Value change
- +$46,553,598
- Number of buys
- 166
- Number of sells
- 117
Report period
Q2 2025
Institutions
281
Top holders
10
PTCT full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
PTC THERAPEUTICS, INC. SEC filings
PTC THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69366J200
Recent filing periods:
Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
8,607,372
|
$438,631,678 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
9.5%
|
7,768,217
|
$395,868,338 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
9.2%
|
7,483,127
|
$381,340,152 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
5,434,843
|
$276,959,599 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.6%
|
5,419,172
|
$276,161,004 | — | 31 Mar 2025 | |
| Camber Capital Management LP |
13D/G
13F
|
Company |
4.2%
|
3,200,000
|
$158,464,000 | $0 | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.6%
|
2,916,729
|
$158,151,955 | — | 31 Mar 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
3.2%
|
2,613,196
|
$133,168,468 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
2,454,896
|
$125,101,500 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.5%
|
2,013,562
|
$102,611,119 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,873,886
|
$95,514,781 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,512,645
|
$77,084,389 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.8%
|
1,445,279
|
$73,651,418 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.7%
|
1,373,573
|
$69,997,302 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
1,273,008
|
$64,872,487 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.6%
|
1,269,647
|
$64,701,212 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
1,167,621
|
$59,501,966 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.3%
|
1,042,458
|
$54,011,142 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.2%
|
1,009,168
|
$51,427,201 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,000,000
|
$50,960,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
949,434
|
$48,383,190 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.91%
|
744,011
|
$37,914,800 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.91%
|
741,002
|
$37,761,462 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.82%
|
670,200
|
$34,153,392 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
662,074
|
$33,739,291 | — | 31 Mar 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.77%
|
628,658
|
$32,036,000 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.74%
|
603,482
|
$30,753,442 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.74%
|
602,665
|
$30,711,808 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.73%
|
595,000
|
$30,321,200 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.71%
|
579,339
|
$29,523,115 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.69%
|
561,839
|
$28,641,189 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
516,127
|
$26,301,831 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.57%
|
468,554
|
$23,878,000 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
460,428
|
$23,463,411 | — | 31 Mar 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.56%
|
455,328
|
$23,203,515 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.54%
|
439,977
|
$22,421,228 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.51%
|
413,023
|
$21,047,652 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.49%
|
404,196
|
$20,597,828 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.42%
|
341,724
|
$17,414,254 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.41%
|
337,960
|
$17,222,442 | — | 31 Mar 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.38%
|
311,777
|
$15,888,156 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.38%
|
310,329
|
$15,814,366 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.37%
|
305,817
|
$15,584,434 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.36%
|
296,567
|
$15,113,054 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.34%
|
280,314
|
$14,284,801 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.34%
|
274,267
|
$13,976,646 | — | 31 Mar 2025 | |
| Man Group plc |
13F
|
Company |
0.32%
|
260,860
|
$13,293,426 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
224,839
|
$11,457,795 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
216,443
|
$11,029,925 | — | 31 Mar 2025 | |
| Stuart Walter Peltz |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
399,365
mixed-class rows
|
$10,876,127 | — | 31 Jan 2023 |
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q2 2025
As of 30 Jun 2025,
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) was held by
281 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,911,059 shares.
The largest 10 holders included
VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock, Inc., ARMISTICE CAPITAL, LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, STATE STREET CORP, TORONTO DOMINION BANK, D. E. Shaw & Co., Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
281
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
260
Q2 2025 holders
281
Holder diff
21
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.